• Jazz Pharmaceuticals Acquires Celator for $1.5 Billion 


    • AveXis – $95 Million IPO 


    • Catabasis Completes $69 Million IPO 


    • HTG Completes its Initial Public Offering 


    • Auspex Pharma $3.5 billion sale to Teva Pharma 


    • Auspex Pharma Acquired by Teva for $3.5 Billion 


    • Bellicum Pharmaceuticals $160 million IPO 


    • Datalogix To Be Acquired by Oracle 


    • Cooley Advises Xencor on its Initial Public Offering 


    • Xenon Pharmaceuticals Completes Initial Public Offering 


    • Ambit Biosciences to be Acquired by Daiichi Sankyo for $410 Million 


    • Vital Therapies Initial Public Offering 


    • Cooley Advises Underwriters on Vital Therapies IPO 


    • Eagle $50 Million Initial Public Offering 


    • Flexion $74 Million Initial Public Offering 


    • Auspex $96 Million Initial Public Offering 


    • Cooley Advised Flexion on Initial Public Offering 


    • Celladon Initial Public Offering 


    • Cooley Advises Auspex on its Initial Public Offering 


    • Xencor Initial Public Offering 


    • Datalogix Sells to Oracle 


    • Ambit Initial Public Offering 


    • Receptos, Inc. Initial Public Offering 


    • Cooley Advises Ambit on its IPO 


    • Insys Therapeutics IPO 


    • Redfin – $159 Million IPO